599 |
Less Use of FFR: Why and How to Overcome |
Nils Johnson |
Dec. 08. 15 |
598 |
Integrated Use of IVUS and FFR in Real Practice |
Jung-Min Ahn |
Dec. 08. 15 |
597 |
Novel Non-Invasive Indices to Define Hemodynamic Forces Acting on Coronary Plaque |
Bon-Kwon Koo |
Dec. 08. 15 |
596 |
Who Needs Adenosine or iFR, I Have cFFR (Contrast FFR): Update on the CONTRAST Study |
William F. Fearon |
Dec. 08. 15 |
595 |
Journey into the Discovery of Coronary Physiology: 20 Years of FFR |
Nico Pijls |
Dec. 08. 15 |
594 |
Can We Prevent Events of Vulnerable Plaques?: From STABLE to PREVENT |
Seung-Jung Park |
Dec. 08. 15 |
593 |
Imaging-Guided BVS Implantation |
Evelyn Regar |
Dec. 08. 15 |
592 |
Rationale for BVS in Vulnerable Plaques |
Michael Joner |
Dec. 08. 15 |
591 |
Long-Term Effect of BVS on Plaque Morphology |
Evelyn Regar |
Dec. 08. 15 |
590 |
Vulnerable Plaques: Natural History and Clinical Outcomes |
Soo-Jin Kang |
Dec. 08. 15 |